Research programme: epilepsy therapeutics - ExonHit Therapeutics
Alternative Names: EHT 207Latest Information Update: 16 Jul 2016
Price :
$50 *
At a glance
- Originator ExonHit Therapeutics
- Developer Eurobio Scientific
- Class Pyrazoles; Pyridines; Small molecules
- Mechanism of Action GABA A receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Epilepsy
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Epilepsy in France
- 19 Dec 2012 ExonHit Therapeutics has merged with InGen Biosciences to form Diaxonhit